Home Tags MabPlex

Tag: MabPlex

Featured Image: MabPlex Building, Yantai, Shandong, China. Courtesy: © 2017 MabPlex. Used with permission.

MabPlex International Secures Series B Financing

MabPlex International, a Contract Development and Manufacturing Organization (CDMO) based in Yantai, the Shandong Peninsula in northeastern Shandong province, in China, confirmed that it...

How the Next Generation Antibody Drug Conjugates Expands Beyond Cytotoxic Payloads...

Antibody-drug Conjugates or ADCs combine the selectivity of antibodies with the efficacy of small molecule drugs, allowing for more precise, targeted, therapeutic applications.Combining the...
MabPlex has started operations of two cell culture production lines of GE brand 2,000-liter single-use bioreactors. Photo Courtesy: MabPlex USA, Inc.

MabPlex Launches Two New Cell Culture Production Lines and Plans Further...

MabPlex International, a fully integrated, Contract Development and Manufacturing Organization (CDMO) with sites in China (Yantai and Shanghai) and the United States (San Diego),...
Featured Image: MabPlex Building, Yantai, Shandong, China. Courtesy: © 2017 MabPlex. Used with permission.

Frost & Sullivan Awards MabPlex with the 2019 Global Growth Excellence...

Based on its recent analysis of the global contract manufacturing services market for antibody-drug conjugate or ADCs, Frost & Sullivan has awarded China-headquarter MabPlex...

Rapidly Expanding MabPlex International Secures U.S. $ 59.1 Million Series A...

In an announcement made to the international business and financial press, MabPlex International, a global Contract Development and Manufacturing Organization or CDMO based in...
MabPlex

MabPlex’s Manufactured Monoclonal Antibody Receives IND Approval from the U.S. Food...

Leading Contract Development and Manufacturing Organization (CDMO) MabPlex International, serving the global biopharmaceutical and biotechnology industries with sites in China and the United States,...

MabPlex Opens New Phase III and Commercial Manufacturing Facility

MabPlex International, a fully integrated Contract Development and Manufacturing Organization (CDMO) with sites in China and the United States, has inaugurated their new manufacturing...

Benefitting from the Worldwide Supply Chain in the development of Antibody-drug...

Timing is everything.Just over a decade ago, the pharmaceutical industry and R&D in China was dominated by generics and plagued with insufficient technical capacity...
Scientist pipetting

Researchers Develop Novel anti-CD19 Antibody-drug Conjugates for the Treatment of B-cell...

In an article published in July 2018 edition of the International Immunopharmacology researchers and scientists from RemeGen (Yantai 264006, Shandong, China) and Mabplex International...
Featured Image: MabPlex Building, Yantai, Shandong, China. Courtesy: © 2017 MabPlex. Used with permission.

Andrew Huang: “ADC’s Are Among the most Powerful Options to...

With a population of 1.4 billion and a rapidly expanding economy, China has become a manufacturing powerhouse. In addition, China is pursuing a...